In RE: Hair Relaxer Marketing, Sales Practices, And Products Liability Litigation

CourtDistrict Court, N.D. Illinois
DecidedAugust 22, 2024
Docket1:23-cv-00818
StatusUnknown

This text of In RE: Hair Relaxer Marketing, Sales Practices, And Products Liability Litigation (In RE: Hair Relaxer Marketing, Sales Practices, And Products Liability Litigation) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In RE: Hair Relaxer Marketing, Sales Practices, And Products Liability Litigation, (N.D. Ill. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

IN RE: HAIR RELAXER MARKETING MDL No. 3060 SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION Master Docket No. 23-cv-0818

Judge Mary M. Rowland

MEMORANDUM OPINION AND ORDER Plaintiffs’ Co-Lead Counsel, Plaintiffs’ Executive Committee, and the Plaintiffs’ Steering Committee (collectively the “PLC”) moved for entry of an order [351] to establish protocols and procedures to govern common benefit fees and expenses in MDL No. 3060. Counsel from Keller Postman LLC, who represents individual Plaintiffs in this MDL, opposed the PLC’s motion [377]. No other counsel objected to the proposed order. For the reasons stated herein, the PLC’s motion is granted in part and denied in part. I. Background On February 6, 2023, the Judicial Panel on Multidistrict Litigation (the “Panel”) transferred to this Court individual and putative class actions pursuant to 28 U.S.C. § 1407 for consolidated pretrial proceedings. See [1]. In centralizing this litigation, the Panel aimed to “obviate the risk of duplicative discovery and inconsistent rulings on pretrial issues,” “minimize duplication of [] expert discovery as well as pretrial motion practice related to expert issues,” and “prevent inconsistent rulings with respect to class certification.” Id. at 2. The Panel concluded consolidation “will allow this litigation to be managed most efficiently and will best serve the convenience of the parties, witnesses, and courts.” Id.

Plaintiffs allege Defendants manufactured, sold, distributed, advertised, and promoted hair relaxer products that caused Plaintiffs to develop cancers and other injuries. [106 ¶ 1]. The complexity and scope of this MDL are significant. Currently more than 8,400 individual cases are pending in this MDL. Any individual Plaintiff may have used multiple different hair relaxer products over the course of her lifetime and accordingly may have asserted claims against multiple Defendants. Plaintiffs

have filed cases against multiple Defendants that are on two separate discovery tracks. Many of these parties are represented by separate counsel. On March 2, 2023, this Court appointed the PLC to promote judicial efficiency and advance these consolidated pretrial proceedings. See Appointment Order [28]. The Appointment Order designated counsel to serve as Co-Lead Counsel and constituted the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee. Id. The Order also set forth non-exhaustive duties of the PLC. Id. at 6–

9. Among the PLC’s broad responsibilities are obligations to communicate with non- PLC Plaintiffs’ counsel, Defendants’ counsel, and the court; to conduct pretrial fact and expert discovery including document review and production, drafting expert reports, and taking or defending depositions; and to submit and argue pretrial motions. Id. Relevant here, the Appointment Order directs “[a]ll attorneys carrying out such common benefit work who may look to any common fund or agreement for reimbursement or compensation [to] maintain and timely submit time and expense records in accordance with guidelines to be set by the Court in a subsequent Case Management Order.” Id. at 6.

In late October 2023, the PLC submitted a proposed CMO (the “Common Benefit Order”) seeking to establish a common benefit fee and expense protocol.1 [278]. The proposed Common Benefit Order defined qualified common benefit work and expenses eligible for reimbursement, created protocols to submit time and expenses for reimbursement, and established procedures to create the common benefit fee and expense fund—including the amount to be assessed or held back from

settlements or judgments for deposit into the fund and the parameters of to whom the proposed order would apply. Id. The PLC submitted a subsequent proposed Common Benefit Order regarding the common benefit fund that is substantially identical to the October 2023 version. [351 at 1; 351-1]. On November 1, 2023, Keller Postman indicated an objection to the PLC’s proposed Common Benefit Fund by filing a motion to extend time to file a response to the PLC’s proposed Common Benefit Order. [280]. Keller Postman is the only

objecting counsel.2 The PLC unanimously supports the proposed CMO. [351 at 1]. After efforts to meet and confer, the PLC and Keller Postman reached an impasse.

1 The PLC initially proposed the at-issue order concerning the common benefit fund as Case Management Order (“CMO”) No. 9. Since that submission, the Court issued CMO No. 9 regarding Plaintiff Fact Sheets and Record Authorization [343], CMO No. 10 regarding Dismissals Without Prejudice [527], CMO No. 11 supplementing CMO Nos. 8 and 9 [648], and CMO No. 12 appointing a Special Master [718].

2 The Court acknowledges the history of negotiations between Keller Postman and the PLC. This history is immaterial to the analysis infra. [322]. Before the Court now is the PLC’s motion to establish the common benefit fund and related procedures. [351]. II. Analysis

a. Application of the Common Benefit Fee The proposed CMO applies to four groups of “Participating Counsel”: (1) all attorneys appointed to various leadership positions by the Court or by the appointed Co-Leads, including all members of the Plaintiffs’ Executive Committee, the Plaintiffs’ Steering Committee, and the Leadership Development Committee, and their respective law firms; (2) any “Affiliated Counsel” who agree to perform work in

the MDL for the common benefit at the direction of the Co-Leads; (3) each attorney or law firm that represents a plaintiff with a case pending, now or in the future, in this MDL, and the order applies to every hair relaxer case in which they or their law firm have a fee interest; and (4) each attorney or law firm that represents hair relaxer claimants, but has no cases filed in the MDL, if the attorney or firm voluntarily elects to sign a Participation Agreement in order to gain the benefits of common benefit work product or that knowingly receives such work product. [351-1 at § 1.A.]. In other

words, under the proposed CMO, assessments would be levied against any recoveries from any hair relaxer claimant if she is represented by counsel with other cases filed in, removed to, or transferred to MDL 3060 regardless of whether a Participation Agreement is executed. The parties do not dispute that the Court may establish a common benefit fund and order contributions to such a fund from cases filed in, removed to, or transferred to this MDL. Likewise, the parties do not contest that the Court may order contributions from cases in which counsel signs a Participation Agreement. The crux of the dispute is whether the Court has the authority to order holdbacks from

recoveries not in the MDL. Specifically, Keller Postman argues the Court lacks authority over recoveries from hair relaxer actions in state court or that are settled before filing in any court. See [377 at 3–9]. The PLC asserts the Court is empowered to order holdbacks under at least three separate sources of judicial authority: (1) the equitable common benefit doctrine; (2) the Court’s inherent managerial power over consolidated litigation; and (3) private contracts. [351 at 4]. The Court disagrees.

The Court’s jurisdiction3 does not extend to cases that are not actually before it even if the plaintiffs in those cases might benefit from work performed in the MDL. In re FedEx Ground Package Sys., Inc., Emp. Pracs. Litig., No. 3:05-MD-527, 2011 WL 611883, at *3 (N.D. Ind. Feb.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Trustees v. Greenough
105 U.S. 527 (Supreme Court, 1882)
Central Railroad & Banking Co. of Ga. v. Pettus
113 U.S. 116 (Supreme Court, 1885)
Mills v. Electric Auto-Lite Co.
396 U.S. 375 (Supreme Court, 1970)
Hall v. Cole
412 U.S. 1 (Supreme Court, 1973)
Alyeska Pipeline Service Co. v. Wilderness Society
421 U.S. 240 (Supreme Court, 1975)
Boeing Co. v. Van Gemert
444 U.S. 472 (Supreme Court, 1980)
In Re Diet Drugs
582 F.3d 524 (Third Circuit, 2009)
Pocius v. Halvorsen
195 N.E.2d 137 (Illinois Supreme Court, 1963)
In Re Vioxx Products Liability Litigation
760 F. Supp. 2d 640 (E.D. Louisiana, 2010)
Degen v. United States
517 U.S. 820 (Supreme Court, 1996)
The Phipps Group v. Don Downing & Adam Levitt, etc
764 F.3d 864 (Eighth Circuit, 2014)
United States v. Moussaoui
483 F.3d 220 (Fourth Circuit, 2007)
Dietz v. Bouldin
579 U.S. 40 (Supreme Court, 2016)
In re Cook Med., Inc.
365 F. Supp. 3d 685 (U.S. District Court, 2019)
Hartland v. Alaska Airlines
544 F.2d 992 (Ninth Circuit, 1976)
Vincent v. Hughes Air West, Inc.
557 F.2d 759 (Ninth Circuit, 1977)

Cite This Page — Counsel Stack

Bluebook (online)
In RE: Hair Relaxer Marketing, Sales Practices, And Products Liability Litigation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-hair-relaxer-marketing-sales-practices-and-products-liability-ilnd-2024.